Protection of cognitive decline and Alzheimer’s disease progression by a human origin‐probiotic biotherapy

Chronic inflammation is a key risk factor for age‐related progression of cognitive decline and Alzheimer’s disease (AD); however, its etiology remains elusive. Multiple emerging evidence indicates that abnormalities in the gut microbiome (dysbiosis) contribute to the pathology of cognitive decline and Alzheimer’s disease, by elevating gut permeability (leaky gut) which in turn instigates inflammation. However, remedies to mitigate cognitive decline and AD progression are not well known.